The company is directing significant capital towards advancing its late-stage pipeline, including candidates for intismeran autogene, norovirus, and a combined flu+COVID vaccine. This R&D push creates a need for solutions in clinical trial management, data analysis, and regulatory affairs to support future product launches.
Filing excerpt
We anticipate maintaining substantial expenses across all areas of our ongoing activities, particularly as we continue research and development of our development candidates and clinical activities for our investigational medicines.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-10qproductLaunchGet every 10-Q signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/621920a9-4871-4003-bf49-029e4e8c58f0 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "621920a9-4871-4003-bf49-029e4e8c58f0",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-05-05T08:48:22.068+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The company is directing significant capital towards advancing its late-stage pipeline, including candidates for intismeran autogene, norovirus, and a combined flu+COVID vaccine. This R&D push creates a need for solutions in clinical trial management, data analysis, and regulatory affairs to support future product launches.",
"metrics": {
"dollar_context": "Significant cash outflows required for R&D and clinical activities"
},
"summary": "Investing heavily in late-stage pipeline, including flu+COVID combo vaccine",
"excerpts": "We anticipate maintaining substantial expenses across all areas of our ongoing activities, particularly as we continue research and development of our development candidates and clinical activities for our investigational medicines.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000060/mrna-20260331.htm",
"filing_date": "2026-05-01",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic"
}
}
curl https://signals.autobound.ai/v1/signals/621920a9-4871-4003-bf49-029e4e8c58f0 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.